Clinical Trials
21 trialsNCT07586826 2026-05-14
N01-A-PICIT-GT
Peking University People's Hospital
Phase 2 Recruiting
NCT06483997 2026-01-29
Diet, Hepcidin, and Chemotherapy RDI
George Washington University
Active not recruiting
NCT04861181 2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4 Terminated
NCT03891576 2025-01-17
Newton
Mario Negri Institute for Pharmacological Research
Phase 2 Terminated
NCT06284343 2024-09-19
GynCAT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT03933813 2023-01-05
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients
University of Wisconsin, Madison
Phase 1/2 Terminated
NCT01272817 2022-11-23
Mini-allo
Scripps Health
Phase NA Completed
NCT04352439 2022-09-26
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
Phase 4 Completed
NCT02039388 2022-09-02
LUSTIC
Medical University of Vienna
Phase NA Completed
NCT05154474 2022-05-03
SPACE2
Weprom
Unknown
NCT01953107 2021-05-12
Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Sunnybrook Health Sciences Centre
Phase 4 Completed
NCT04474951 2020-07-17
GALENO 1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Unknown
NCT03889171 2019-03-28
PSICOM
University Hospital, Montpellier
Completed
NCT02418624 2019-01-16
REVIVAL
The Netherlands Cancer Institute
Phase 1 Completed
NCT02480790 2018-10-05
Venous Thromboembolic Complications in Ovarian Cancer
Aalborg University Hospital
Unknown
NCT00419510 2016-08-17
Genetic Counseling in African American Women
University of Pennsylvania
Phase NA Completed
NCT01346761 2016-04-14
REACH
University of Utah
Phase NA Completed
NCT00776958 2014-07-31
Lynne Cohen Consortium Project: Multi-Center Database/Registry
M.D. Anderson Cancer Center
Completed
NCT01772979 2013-01-21
MITO15
Catholic University of the Sacred Heart
Phase 2 Unknown
NCT00165152 2012-08-09
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
Dana-Farber Cancer Institute
Phase NA Completed
NCT00155896 2005-09-12
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
National Taiwan University Hospital
Unknown